pyridoxal phosphate has been researched along with Cancer of Pancreas in 24 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Excerpt | Relevance | Reference |
---|---|---|
"Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate) (DPDP) was tested as a contrast agent for magnetic resonance imaging of pancreatic adenocarcinoma in 15 patients." | 5.07 | Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience. ( Bohndorf, K; Gehl, HB; Günther, RW; Hauptmann, S; Klever, P; Lodemann, KP; Matern, S; Schumpelick, V; Urhahn, R, 1993) |
" Conditional logistic regression was used to calculate the odds ratios (OR) and 95% confidence intervals (CI), adjusting for education, smoking status, plasma cotinine concentration, alcohol drinking, body mass index and diabetes status." | 3.77 | A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. ( Benetou, V; Boeing, H; Boutron-Ruault, MC; Bueno-de-Mesquita, B; Chuang, SC; Clavel-Chapelon, F; Crowe, F; Duell, EJ; Gurrea, AB; Huerta, JM; Jenab, M; Jeurnink, S; Johansen, D; Kaaks, R; Khaw, KT; Larrañaga, N; Manjer, J; Michaud, DS; Midttun, Ø; Molina-Montes, E; Morois, S; Naska, A; Olsen, A; Overvad, K; Palli, D; Panico, S; Peeters, PH; Riboli, E; Rodriguez, L; Romieu, I; Sacerdote, C; Sieri, S; Skeie, G; Slimani, N; Stolzenberg-Solomon, R; Sund, M; Teucher, B; Tjønneland, A; Trichopoulou, A; Tumino, R; Ueland, PM; Vineis, P; Vollset, SE; Wareham, N; Weikert, C; Ye, W, 2011) |
"20 patients with suspected pancreatic cancer were included in a phase III study." | 2.69 | MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT. ( Brambs, HJ; Klaus, H; Nüssle, K; Rieber, A; Tomczak, R, 2000) |
"Insulinoma is the most common pancreatic endocrine tumor." | 2.42 | Mangan-enhanced MR imaging for the detection and localisation of small pancreatic insulinoma. ( Aboalmaali, N; Hamoud, AK; Khan, MF; Usadel, KH; Vogl, TJ; Wullstein, C, 2004) |
"Mangafodopir may improve the staging of pancreatic cancer by increasing the sensitivity of MRI in the detection of liver metastases." | 2.41 | Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT. ( Függer, R; Schima, W, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (33.33) | 18.2507 |
2000's | 13 (54.17) | 29.6817 |
2010's | 3 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, JY | 2 |
Butler, LM | 2 |
Midttun, Ø | 3 |
Ulvik, A | 1 |
Wang, R | 2 |
Jin, A | 2 |
Gao, YT | 2 |
Ueland, PM | 3 |
Koh, WP | 2 |
Yuan, JM | 2 |
Boraschi, P | 1 |
Donati, F | 1 |
Gigoni, R | 1 |
Salemi, S | 1 |
Faggioni, L | 1 |
Del Chiaro, M | 1 |
Boggi, U | 1 |
Bartolozzi, C | 1 |
Falaschi, F | 1 |
Chuang, SC | 1 |
Stolzenberg-Solomon, R | 1 |
Vollset, SE | 1 |
Olsen, A | 1 |
Tjønneland, A | 1 |
Overvad, K | 1 |
Boutron-Ruault, MC | 1 |
Morois, S | 1 |
Clavel-Chapelon, F | 1 |
Teucher, B | 1 |
Kaaks, R | 1 |
Weikert, C | 1 |
Boeing, H | 1 |
Trichopoulou, A | 1 |
Benetou, V | 1 |
Naska, A | 1 |
Jenab, M | 1 |
Slimani, N | 1 |
Romieu, I | 1 |
Michaud, DS | 1 |
Palli, D | 1 |
Sieri, S | 1 |
Panico, S | 1 |
Sacerdote, C | 1 |
Tumino, R | 1 |
Skeie, G | 1 |
Duell, EJ | 1 |
Rodriguez, L | 1 |
Molina-Montes, E | 1 |
Huerta, JM | 1 |
Larrañaga, N | 1 |
Gurrea, AB | 1 |
Johansen, D | 1 |
Manjer, J | 1 |
Ye, W | 1 |
Sund, M | 1 |
Peeters, PH | 1 |
Jeurnink, S | 1 |
Wareham, N | 1 |
Khaw, KT | 1 |
Crowe, F | 1 |
Riboli, E | 1 |
Bueno-de-Mesquita, B | 1 |
Vineis, P | 1 |
Schima, W | 4 |
Függer, R | 2 |
Schober, E | 1 |
Oettl, C | 1 |
Wamser, P | 1 |
Grabenwöger, F | 1 |
Ryan, JM | 1 |
Novacek, G | 1 |
Hamoud, AK | 1 |
Khan, MF | 1 |
Aboalmaali, N | 1 |
Usadel, KH | 1 |
Wullstein, C | 1 |
Vogl, TJ | 1 |
Ramsay, D | 1 |
Marshall, M | 1 |
Song, S | 1 |
Zimmerman, M | 1 |
Edmunds, S | 1 |
Yusoff, I | 1 |
Cullingford, G | 1 |
Fletcher, D | 1 |
Mendelson, R | 1 |
Zanello, A | 1 |
Nicoletti, R | 1 |
Brambilla, P | 1 |
Boccuni, R | 1 |
Di Carlo, V | 1 |
Staudacher, C | 1 |
Del Maschio, A | 1 |
Sahani, DV | 1 |
Kalva, SP | 1 |
Fischman, AJ | 1 |
Kadavigere, R | 1 |
Blake, M | 1 |
Hahn, PF | 1 |
Saini, S | 2 |
Eser, G | 1 |
Karabacakoglu, A | 1 |
Karakose, S | 1 |
Eser, C | 1 |
Kayacetin, E | 1 |
De Filippo, M | 1 |
Bocchi, C | 1 |
Quartieri, L | 1 |
Corradi, D | 1 |
Zompatori, M | 1 |
Gehl, HB | 3 |
Günther, RW | 2 |
Klever, P | 2 |
Hauptmann, S | 2 |
Urhahn, R | 1 |
Bohndorf, K | 1 |
Lodemann, KP | 1 |
Matern, S | 1 |
Schumpelick, V | 1 |
Kettritz, U | 1 |
Semelka, RC | 1 |
Ahlström, H | 1 |
Mayo-Smith, WW | 1 |
Slater, GJ | 1 |
McFarland, EG | 1 |
Wang, C | 1 |
Mathieu, D | 1 |
Coffin, C | 1 |
Kobeiter, H | 1 |
Caseiro-Alves, F | 1 |
Mahfouz, A | 1 |
Rahmouni, A | 1 |
Diche, T | 1 |
Diehl, SJ | 1 |
Lehmann, KJ | 1 |
Gaa, J | 1 |
McGill, S | 1 |
Hoffmann, V | 1 |
Georgi, M | 1 |
Romijn, MG | 1 |
Stoker, J | 1 |
van Eijck, CH | 1 |
van Muiswinkel, JM | 1 |
Torres, CG | 1 |
Laméris, JS | 1 |
Rieber, A | 1 |
Tomczak, R | 1 |
Nüssle, K | 1 |
Klaus, H | 1 |
Brambs, HJ | 1 |
Dobritz, M | 1 |
Fellner, FA | 1 |
Baum, U | 1 |
Nömayr, A | 1 |
Lell, M | 1 |
Klein, P | 1 |
Papadopoulos, T | 1 |
Bautz, W | 1 |
5 reviews available for pyridoxal phosphate and Cancer of Pancreas
Article | Year |
---|---|
Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT.
Topics: Contrast Media; Edetic Acid; Humans; Laparotomy; Magnetic Resonance Imaging; Neoplasm Staging; Pancr | 2002 |
Mangan-enhanced MR imaging for the detection and localisation of small pancreatic insulinoma.
Topics: Contrast Media; Edetic Acid; Humans; Insulinoma; Laparoscopy; Magnetic Resonance Imaging; Pancreas; | 2004 |
Contrast-enhanced MR imaging of the pancreas.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mangan | 1996 |
Overview of MnDPDP as a pancreas-specific contrast agent for MR imaging.
Topics: Acute Disease; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Manganese; Pancreas; | 1997 |
Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
Topics: Adenoma, Islet Cell; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance | 1999 |
6 trials available for pyridoxal phosphate and Cancer of Pancreas
Article | Year |
---|---|
[Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings].
Topics: Adenocarcinoma; Adenoma, Islet Cell; Chronic Disease; Contrast Media; Edetic Acid; Humans; Magnetic | 1993 |
Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
Topics: Adenocarcinoma; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Manga | 1993 |
Pancreatic enhancement and pulse sequence analysis using low-dose mangafodipir trisodium.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Manganes | 1998 |
MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
Topics: Adult; Aged; Carcinoma, Ductal, Breast; Chronic Disease; Contrast Media; Diagnosis, Differential; Ed | 1999 |
MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans | 2000 |
MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Image Processing, Compu | 2000 |
13 other studies available for pyridoxal phosphate and Cancer of Pancreas
Article | Year |
---|---|
A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer.
Topics: 3-Hydroxyanthranilic Acid; Biomarkers; Case-Control Studies; China; Female; Humans; Kynurenine; Male | 2018 |
Serum B
Topics: Aged; Asian People; Biomarkers, Tumor; Case-Control Studies; Female; Humans; Male; Middle Aged; Panc | 2016 |
Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Ima | 2009 |
A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.
Topics: Adult; Aged; Alcohol Drinking; Body Mass Index; Case-Control Studies; Cotinine; Diabetes Complicatio | 2011 |
Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid | 2002 |
[Organ specific MRI contrast media in general practice].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Lung Neop | 2002 |
Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging.
Topics: Contrast Media; Edetic Acid; Endosonography; Female; Humans; Lymphatic Metastasis; Magnetic Resonanc | 2004 |
Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Middle A | 2004 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxygluc | 2005 |
Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver N | 2006 |
Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.
Topics: Adenocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Edetic Acid; Female | 2007 |
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Bar | 1998 |
[MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation].
Topics: Ampulla of Vater; Biopsy, Needle; Common Bile Duct Neoplasms; Contrast Media; Edetic Acid; Humans; I | 2002 |